Hong Kong Stock Movement | Alebund Pharmaceuticals-B (09637.HK) rose nearly 8% in the afternoon; AP308/PKU308 received U.S. FDA clinical trial authorization.

Zhito Finance APP has learned that Alebund Pharmaceuticals-B (09637.HK) rose nearly 8% in the afternoon session. As of press time, it was up 5.72%, at HK$24.78, with a turnover of HK$12.7144 million.